# 129Xe MRI in Pediatric Population With BPD

> **NCT04035629** · PHASE1 · WITHDRAWN · sponsor: **Xemed LLC**

## Conditions studied

- Bronchopulmonary Dysplasia

## Interventions

- **COMBINATION_PRODUCT:** MagniXene, hyperpolarized 129Xe MRI

## Key facts

- **NCT ID:** NCT04035629
- **Lead sponsor:** Xemed LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2026-08-01
- **Primary completion:** 2031-07-31
- **Final completion:** 2031-12-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Did not secure funding.
- **Last updated:** 2026-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04035629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04035629, "129Xe MRI in Pediatric Population With BPD". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04035629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*